Study Details
- Type: Multicentric
- Disease: Covid 19 Surveillance of positive tests
- Primary Site: Fondazione Policlinico Gemelli
- Start: March 2021
- Population: Outpatient pulmonary adults with documented positive SARS-CoV-2 test
- Duration: Ongoing
Study Description
IPF VACCINE is a study to record and monitor Idiopathic pulmonary fibrosis (IPF) patients of the Agostino Gemelli IRCCS University Hospital Foundation after the administration of their vaccination. Healthentia application will be used to collect through questionnaires, any side effects that occurred on the day of vaccination and the following seven days.
Study Design & Method
All participants will download Healthentia application and register. For a period of 7 days, the user is asked, through an agile questionnaire, to report any side effects that occurred on the day of vaccination and the next seven days.
Monitor reactions on IPF Patients
Categorize side effects present in
IPF Patient group
